Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Florida, USA.
Am J Ophthalmol. 2012 May;153(5):804-814.e1. doi: 10.1016/j.ajo.2011.10.024. Epub 2012 Jan 14.
To describe postoperative complications encountered in the Tube Versus Trabeculectomy (TVT) Study during 5 years of follow-up.
Multicenter randomized clinical trial.
Seventeen clinical centers.
Patients 18 to 85 years of age who had previous trabeculectomy and/or cataract extraction with intraocular lens implantation and uncontrolled glaucoma with intraocular pressure (IOP) ≥18 mm Hg and ≤40 mm Hg on maximum tolerated medical therapy.
Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC 0.4 mg/mL for 4 minutes).
Surgical complications, reoperations for complications, visual acuity, and cataract progression.
Early postoperative complications occurred in 22 patients (21%) in the tube group and 39 patients (37%) in the trabeculectomy group (P = .012). Late postoperative complications developed in 36 patients (34%) in the tube group and 38 patients (36%) in the trabeculectomy group during 5 years of follow-up (P = .81). The rate of reoperation for complications was 22% in the tube group and 18% in the trabeculectomy group (P = .29). Cataract extraction was performed in 13 phakic eyes (54%) in the tube group and 9 phakic eyes (43%) in the trabeculectomy group (P = .43).
A large number of surgical complications were observed in the TVT Study, but most were transient and self-limited. The incidence of early postoperative complications was higher following trabeculectomy with MMC than tube shunt surgery. The rates of late postoperative complications, reoperation for complications, and cataract extraction were similar with both surgical procedures after 5 years of follow-up.
描述 Tube Versus Trabeculectomy(TVT)研究在 5 年随访期间遇到的术后并发症。
多中心随机临床试验。
17 个临床中心。
年龄在 18 至 85 岁之间的患者,他们之前接受过小梁切除术和/或白内障摘除术,同时植入人工晶状体,并伴有药物治疗无法控制的青光眼,眼内压(IOP)为 18mmHg 至 40mmHg 之间。
引流管(350mm² Baerveldt 青光眼植入物)或小梁切除术联合丝裂霉素 C(MMC 0.4mg/mL 作用 4 分钟)。
手术并发症、并发症再手术、视力和白内障进展。
在引流管组有 22 例(21%)患者和在小梁切除术组有 39 例(37%)患者发生早期术后并发症(P=0.012)。在 5 年随访期间,引流管组有 36 例(34%)患者和小梁切除术组有 38 例(36%)患者出现晚期术后并发症(P=0.81)。引流管组并发症再手术率为 22%,小梁切除术组为 18%(P=0.29)。在引流管组中有 13 例(54%)有晶状体眼患者和在小梁切除术组中有 9 例(43%)有晶状体眼患者接受白内障摘除术(P=0.43)。
TVT 研究中观察到大量手术并发症,但大多数是短暂的、自限性的。与引流管手术相比,MMC 小梁切除术的早期术后并发症发生率更高。在 5 年随访后,两种手术方式的晚期术后并发症、并发症再手术率和白内障摘除率相似。